← AMS Home🩸 Theranos — A $9 Billion Valuation Built on a Machine That Didn't Work
Theranos told investors and the public that its small blood analyzer could perform a broad menu of tests from a fingerstick. Trial evidence showed the device could perform only a few basic tests reliably and that the company relied heavily on conventional machines. Patients faced unreliable results—but Holmes's four convictions were for defrauding investors, not patients.
🔬 AMS Core Frame
Theranos combined two different harms: inaccurate medical testing and false representations used to raise capital. They overlap factually but not automatically in law. The jury convicted Holmes on investor counts, acquitted her on the patient conspiracy and three patient wire-fraud counts, and could not reach verdicts on three other investor counts.